A 31-year-old man suffered 6 months of rigors with only partial benefit from treatment of presumed chest infections. He previously had an internal cardioverter-defibrillator (ICD) fitted 7 years earlier for ventricular tachycardia ( Figure A and B) due to arrhythmogenic right ventricular cardiomyopathy (ARVC).
His general practitioner consulted a rheumatologist who suggested a whole body 18 F fluorodeoxyglucose positron emission tomography (FDG-PET) scan to localize the suspected infection/inflammation. Avid uptake (arrows, Figure C ) was present in the superior vena cava and right atrium.
He was transferred to our care. Transoesophageal echocardiography showed large vegetations on the ICD lead and tricuspid valve ( Figure D , see Supplementary data online, Movie S1). Consecutive sets of blood cultures grew coagulase-negative Staphylococcus aureus.
Antimicrobial therapy failed to reduce the vegetations size or settle the infection, and surgical lead extraction was performed ( Figure E ) with vegetations also cleared from the tricuspid valve. Culture of the surgical specimen grew the same organism.
The patient received further intravenous antibiotics before a new ICD was fitted. During this time, a cardiac MRI scan ( Figure F , see Supplementary data online, Movie S2) documented severe RV impairment and areas of akinesia/microaneurysms along the RV-free wall, typical for ARVC. Late gadolinium enhancement was present in several areas, indicative of fibrosis ( Figure G, arrows) . The patient has been symptomfree since with no evidence of infection on follow-up.
FDG-PET is a highly unusual imaging tool for identifying device endocarditis but was used initially when a cardiovascular source of infection was not suspected. Nonetheless, it showed good ability to localize the infection, subsequently confirmed by more conventional imaging methods. Its value as a first line investigation is controversial however.
Supplementary data are available at European Heart Journal -Cardiovascular Imaging online. 
